Cate RL - Search Results

1

Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment.

Pepinsky RB, Sinclair LK, Chow EP, Mattaliano RJ, Manganaro TF, Donahoe PK, Cate RL. Pepinsky RB, et al. Among authors: cate rl. J Biol Chem. 1988 Dec 15;263(35):18961-4. J Biol Chem. 1988. PMID: 2974034 Free article.

2

The anti-Müllerian hormone prodomain is displaced from the hormone/prodomain complex upon bivalent binding to the hormone receptor.

Cate RL, di Clemente N, Racine C, Groome NP, Pepinsky RB, Whitty A. Cate RL, et al. J Biol Chem. 2022 Jan;298(1):101429. doi: 10.1016/j.jbc.2021.101429. Epub 2021 Nov 19. J Biol Chem. 2022. PMID: 34801555 Free PMC article.

3

Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.

Wilson CA, di Clemente N, Ehrenfels C, Pepinsky RB, Josso N, Vigier B, Cate RL. Wilson CA, et al. Among authors: cate rl. Mol Endocrinol. 1993 Feb;7(2):247-57. doi: 10.1210/mend.7.2.8469238. Mol Endocrinol. 1993. PMID: 8469238

4

Isolation of the rat gene for Mullerian inhibiting substance.

Haqq C, Lee MM, Tizard R, Wysk M, DeMarinis J, Donahoe PK, Cate RL. Haqq C, et al. Among authors: cate rl. Genomics. 1992 Apr;12(4):665-9. doi: 10.1016/0888-7543(92)90291-y. Genomics. 1992. PMID: 1572639

5

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.

Hudson PL, Dougas I, Donahoe PK, Cate RL, Epstein J, Pepinsky RB, MacLaughlin DT. Hudson PL, et al. Among authors: cate rl. J Clin Endocrinol Metab. 1990 Jan;70(1):16-22. doi: 10.1210/jcem-70-1-16. J Clin Endocrinol Metab. 1990. PMID: 2294129

6

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells.

Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP, et al. Cate RL, et al. Cell. 1986 Jun 6;45(5):685-98. doi: 10.1016/0092-8674(86)90783-x. Cell. 1986. PMID: 3754790

7

Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.

Lee MM, Cate RL, Donahoe PK, Waneck GL. Lee MM, et al. Among authors: cate rl. Endocrinology. 1992 Feb;130(2):847-53. doi: 10.1210/endo.130.2.1346380. Endocrinology. 1992. PMID: 1346380

8

Constitutive negative regulation in the processing of the anti-Müllerian hormone receptor II.

Hirschhorn T, di Clemente N, Amsalem AR, Pepinsky RB, Picard JY, Smorodinsky NI, Cate RL, Ehrlich M. Hirschhorn T, et al. Among authors: cate rl. J Cell Sci. 2015 Apr 1;128(7):1352-64. doi: 10.1242/jcs.160143. Epub 2015 Feb 6. J Cell Sci. 2015. PMID: 25663701

9

Development of mullerian inhibiting substance as an anti-cancer drug.

Cate RL, Ninfa EG, Pratt DJ, MacLaughlin DT, Donahoe PK. Cate RL, et al. Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:641-7. doi: 10.1101/sqb.1986.051.01.076. Cold Spring Harb Symp Quant Biol. 1986. PMID: 3472743 No abstract available.

10

Most Cleaved Anti-Müllerian Hormone Binds Its Receptor in Human Follicular Fluid but Little Is Competent in Serum.

Pierre A, Racine C, Rey RA, Fanchin R, Taieb J, Cohen-Tannoudji J, Carmillo P, Pepinsky RB, Cate RL, di Clemente N. Pierre A, et al. Among authors: cate rl. J Clin Endocrinol Metab. 2016 Dec;101(12):4618-4627. doi: 10.1210/jc.2016-1742. Epub 2016 Sep 13. J Clin Endocrinol Metab. 2016. PMID: 27623067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters